Apple Inc. ($AAPL) held a special media event on August 21 showcasing new health-focused features that will debut with the upcoming iPhone 17 lineup, expected to be announced on September 9 . The company unveiled a groundbreaking non-invasive blood glucose monitoring system that utilizes advanced optical sensors, eliminating the need for finger-prick testing . This feature, which has been in development for over a decade, uses Raman spectroscopy to measure glucose levels through the skin . Apple shares gained approximately 1.5% on the news, with analysts noting this could be a significant catalyst for iPhone sales as health-conscious consumers seek devices with advanced wellness capabilities . The company also announced partnerships with major medical institutions for clinical validation studies, emphasizing its commitment to making the iPhone a comprehensive health management tool .
#GateStockInsightsChallenge

AAPL-1.76%

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

9 Likes39 views

Reward
9
15
1
Share

Comment

Add a comment

GoldenCrossFan

· 34m ago

If this noninvasive blood glucose feature really comes to fruition, Apple won’t just be a phone maker anymore—it’ll become a medical device giant.

Reply0

LongShortWatcher

· 41m ago

The biggest highlight of the iPhone 17 is surprisingly not its chip but its health monitoring—Cook made a brilliant move.

Reply0

AllowanceExpirer

· 46m ago

Non-invasive blood glucose sounds like science fiction, but Raman spectroscopy has been around for so many years—is it reliable? Let’s wait for real-world testing.

Reply0

FloorTrap

· 51m ago

Health-conscious users would definitely pay for this. If my dad knew about it, he’d definitely want to switch phones.

Reply0

DogeNoBuy

· 52m ago

The highlight is blood glucose, but future healthcare partnerships are the moat—ordinary manufacturers simply can’t afford to go this deep.

Reply0

AddressZero

· 56m ago

A decade of R&D has resulted in a non-invasive glucose monitor. That patience is truly admirable, though the price will probably skyrocket again.

Reply0

MAGridWorker

· 58m ago

Apple is turning smartphones into health management tools—this direction is far smarter than simply piling on specs, and its ecosystem advantage will only grow.

Reply0

AntiRugFarmer

· 59m ago

What I care about isn’t how powerful the functionality is, but how accurate it is. If the test happens to show a large margin of error, it could mislead people instead.

Reply0

CrossChainPiggy

· 59m ago

The 1.5% gain shows that the market approves, but clinical validation and regulatory approval are the real hurdles.

Reply0

SlitherRunner

· 59m ago

Will blood sugar testing no longer require finger pricks? Diabetic patients really should thank Apple—this technology is far more meaningful than something like the Dynamic Island.

Reply0

Trending Topics
View More
#
BTCBreaks71000Up10.5%
609.83M Popularity
#
ETHSurges20%BreaksThrough2300
33.37M Popularity
#
BTCETHReboundTradeIdeas
90.38K Popularity
#
USTreasuryBuybacksAndRegulatorySignalsDriveCryptoSurge
2.95M Popularity
#
StrategySurgesNearly12%
792.53K Popularity

Pinned

Sitemap

$AAPL - Apple Unveils New Health-Focused Features Ahead of iPhone 17 Launch

Trending Topics

BTCBreaks71000Up10.5%

ETHSurges20%BreaksThrough2300

BTCETHReboundTradeIdeas

USTreasuryBuybacksAndRegulatorySignalsDriveCryptoSurge

StrategySurgesNearly12%

Pinned